Drug product
Elelyso (taliglucerase alfa) for injection, 200 units/vials,, Rx only, Distributed by Pfizer Labs, Division of Pfizer Inc, NY, NY 10017. NDC 0069-0106-01
D-0995-2020
Product summary
- Firm
- Pfizer Inc.
- Event
- Event 85067
- Status
- Terminated
- Classification
- Class II
- Quantity
- 24,714 vials
- Official record key
drug-enforcement:D-0995-2020
Official wording
Reason: Lack of Assurance of Sterility--Reports of loose metal ferrule crimps on vials for injection. The entire cap either lifted or dislodged while attempting to flip off the orange color plastic button.
Code information: Lot #: X14209, Exp. Date 02/2020; AH4601, Exp. Date 03/2020; AH4603, X46389, X78365, AT2927, Exp. Date 04/2020; AH4602, Exp. Date 05/2020; AL8590, Exp. Date 10/2020
Distribution pattern: Nationwide within the United States and Albania, Israel, Serbia, Macedonia, Afghanistan, Botswana/South Africa/Zimbabwe, India, Israel, Rwanda, Uruguay, Mongolia
Derived failure modes
-
Sterility assurance
Lack of Assurance of Sterility